Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q1 2017 · 10-Q
Revenue$46.02K$46.02K+230.1% vs Q1 2016 Net Income-$2.33M-$2.33MN/M vs Q1 2016 EPS Diluted-$0.02-$0.02N/M vs Q1 2016 Gross Profit$23,487+198.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Operating Cash Flow-$1,176,252N/M Margins · derivedGross margin51.0%−5.3 pt vs Q1 2016
Operating margin-3109.3%+6048.8 pt vs Q1 2016
Net margin-5053.9%+6740.6 pt vs Q1 2016
ended Mar 31, 2017 · filed May 17, 2017 · 47 d after period end